{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T23:30:34Z","timestamp":1774395034471,"version":"3.50.1"},"reference-count":81,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011676","name":"Elekta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011676","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.soc.2020.08.006","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T10:31:38Z","timestamp":1603189898000},"page":"159-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["External Beam Radiation Therapy for Liver Metastases"],"prefix":"10.1016","volume":"30","author":[{"given":"Paul B.","family":"Romesser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian P.","family":"Neal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher H.","family":"Crane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.soc.2020.08.006_bib1","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.3748\/wjg.v20.i24.7602","article-title":"Palliative care and end-stage colorectal cancer management: the surgeon meets the oncologist","volume":"20","author":"Costi","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.soc.2020.08.006_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.clon.2015.01.032","article-title":"Stereotactic body radiotherapy for liver metastases","volume":"27","author":"Aitken","year":"2015","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3","key":"10.1016\/j.soc.2020.08.006_bib3","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.semradonc.2017.02.004","article-title":"Stereotactic body radiotherapy for liver metastases","volume":"27","author":"Goodman","year":"2017","journal-title":"Semin Radiat Oncol"},{"issue":"1","key":"10.1016\/j.soc.2020.08.006_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2020.08.006_bib5","doi-asserted-by":"crossref","first-page":"29765","DOI":"10.1038\/srep29765","article-title":"Patterns of metastasis in colon and rectal cancer","volume":"6","author":"Riihimaki","year":"2016","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.soc.2020.08.006_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.7326\/0003-4819-122-5-199503010-00001","article-title":"Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report","volume":"122","author":"Moertel","year":"1995","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.soc.2020.08.006_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","article-title":"Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases","volume":"230","author":"Fong","year":"1999","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.soc.2020.08.006_bib8","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/bjs.7032","article-title":"Surgical management and outcomes of colorectal cancer liver metastases","volume":"97","author":"Morris","year":"2010","journal-title":"Br J Surg"},{"issue":"7","key":"10.1016\/j.soc.2020.08.006_bib9","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.0.CO;2-I","article-title":"Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Assoc Francaise de Chirurgie","volume":"77","author":"Nordlinger","year":"1996","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.soc.2020.08.006_bib10","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.athoracsur.2009.03.034","article-title":"Prognostic factors for recurrence after pulmonary resection of colorectal cancer metastases","volume":"87","author":"Onaitis","year":"2009","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.soc.2020.08.006_bib11","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00000658-200206000-00002","article-title":"Trends in long-term survival following liver resection for hepatic colorectal metastases","volume":"235","author":"Choti","year":"2002","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.soc.2020.08.006_bib12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1365-2168.1999.01010.x","article-title":"Sequential hepatic and pulmonary resections for metastatic colorectal cancer","volume":"86","author":"Lehnert","year":"1999","journal-title":"Br J Surg"},{"issue":"3","key":"10.1016\/j.soc.2020.08.006_bib13","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jamcollsurg.2005.11.008","article-title":"Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma","volume":"202","author":"Shah","year":"2006","journal-title":"J\u00a0Am Coll Surg"},{"issue":"12","key":"10.1016\/j.soc.2020.08.006_bib14","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/archsurg.1992.01420120037006","article-title":"Lung resection for colorectal metastases. 10-year results","volume":"127","author":"McCormack","year":"1992","journal-title":"Arch Surg"},{"issue":"4","key":"10.1016\/j.soc.2020.08.006_bib15","first-page":"524","article-title":"Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model","volume":"244","author":"Adam","year":"2006","journal-title":"Ann Surg"},{"issue":"9783","key":"10.1016\/j.soc.2020.08.006_bib16","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0140-6736(11)60788-5","article-title":"First-line treatment of advanced colorectal cancer","volume":"377","author":"Hewish","year":"2011","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.soc.2020.08.006_bib17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/jamaoncol.2015.1790","article-title":"Colorectal cancer survival gains and novel treatment regimens: a systematic review and analysis","volume":"1","author":"Jawed","year":"2015","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.soc.2020.08.006_bib18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s13046-019-1266-0","article-title":"Advances in cancer immunotherapy 2019 - latest trends","volume":"38","author":"Kruger","year":"2019","journal-title":"J\u00a0Exp Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.soc.2020.08.006_bib19","first-page":"3","article-title":"Progress of immune checkpoint therapy in the clinic (Review)","volume":"41","author":"Fan","year":"2019","journal-title":"Oncol Rep"},{"issue":"10","key":"10.1016\/j.soc.2020.08.006_bib20","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S1470-2045(14)70330-4","article-title":"FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial","volume":"15","author":"Heinemann","year":"2014","journal-title":"Lancet Oncol"},{"issue":"15","key":"10.1016\/j.soc.2020.08.006_bib21","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/S0959-8049(03)00553-7","article-title":"The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours","volume":"39","author":"Garcea","year":"2003","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.soc.2020.08.006_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx015","article-title":"Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial","volume":"109","author":"Ruers","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.soc.2020.08.006_bib23","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/annonc\/mds053","article-title":"Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)","volume":"23","author":"Ruers","year":"2012","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.soc.2020.08.006_bib24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1200\/JCO.2009.23.4450","article-title":"American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer","volume":"28","author":"Wong","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.soc.2020.08.006_bib25","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.ijrobp.2011.07.020","article-title":"Radiotherapy for liver metastases: a review of evidence","volume":"82","author":"Hoyer","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.soc.2020.08.006_bib26","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1046\/j.1440-1673.2003.01177.x","article-title":"A\u00a0prospective trial of short-fractionation radiotherapy for the palliation of liver metastases","volume":"47","author":"Bydder","year":"2003","journal-title":"Australas Radiol"},{"issue":"5","key":"10.1016\/j.soc.2020.08.006_bib27","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0360-3016(81)90370-9","article-title":"The palliation of hepatic metastases: results of the Radiation Therapy Oncology Group pilot study","volume":"7","author":"Borgelt","year":"1981","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"31","key":"10.1016\/j.soc.2020.08.006_bib28","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1200\/JCO.2013.49.9202","article-title":"Phase II trial of palliative radiotherapy for hepatocellular carcinoma and liver metastases","volume":"31","author":"Soliman","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.soc.2020.08.006_bib29","first-page":"597","article-title":"The human liver after radiation injury. A form of veno-occlusive disease","volume":"48","author":"Reed","year":"1966","journal-title":"Am J Pathol"},{"key":"10.1016\/j.soc.2020.08.006_bib30","first-page":"200","article-title":"Radiation Hepatitis","volume":"93","author":"Ingold","year":"1965","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"issue":"5","key":"10.1016\/j.soc.2020.08.006_bib31","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0360-3016(94)00418-K","article-title":"Hepatic toxicity resulting from cancer treatment","volume":"31","author":"Lawrence","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"suppl_1","key":"10.1016\/j.soc.2020.08.006_bib32","doi-asserted-by":"crossref","first-page":"i40","DOI":"10.1093\/jrr\/rrx104","article-title":"Strategies for prediction and mitigation of radiation-induced liver toxicity","volume":"59","author":"Toesca","year":"2018","journal-title":"J\u00a0Radiat Res"},{"issue":"3 Suppl","key":"10.1016\/j.soc.2020.08.006_bib33","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.ijrobp.2009.06.092","article-title":"Radiation-associated liver injury","volume":"76","author":"Pan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.soc.2020.08.006_bib34","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1200\/JCO.1993.11.7.1286","article-title":"Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy","volume":"11","author":"Robertson","year":"1993","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.soc.2020.08.006_bib35","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0360-3016(94)00471-4","article-title":"Analysis of clinical complication data for radiation hepatitis using a parallel architecture model","volume":"31","author":"Jackson","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.soc.2020.08.006_bib36","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0360-3016(96)00528-7","article-title":"Long-term results of hepatic artery fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers","volume":"37","author":"Robertson","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.soc.2020.08.006_bib37","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1200\/JCO.2000.18.11.2210","article-title":"Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies","volume":"18","author":"Dawson","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.soc.2020.08.006_bib38","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/0360-3016(92)90651-W","article-title":"The use of 3-D dose volume analysis to predict radiation hepatitis","volume":"23","author":"Lawrence","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.soc.2020.08.006_bib39","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0360-3016(02)02846-8","article-title":"Analysis of radiation-induced liver disease using the Lyman NTCP model","volume":"53","author":"Dawson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"34","key":"10.1016\/j.soc.2020.08.006_bib40","doi-asserted-by":"crossref","first-page":"8739","DOI":"10.1200\/JCO.2005.01.5354","article-title":"Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies","volume":"23","author":"Ben-Josef","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.soc.2020.08.006_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0167-8140(02)00061-0","article-title":"Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: clinical manifestation and dosimetric description","volume":"63","author":"Cheng","year":"2002","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.soc.2020.08.006_bib42","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.ijrobp.2004.05.048","article-title":"Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease","volume":"60","author":"Cheng","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.soc.2020.08.006_bib43","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ijrobp.2005.12.031","article-title":"Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance","volume":"65","author":"Liang","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.soc.2020.08.006_bib44","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3109\/02841869509127197","article-title":"Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients","volume":"34","author":"Blomgren","year":"1995","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1016\/j.soc.2020.08.006_bib45","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1200\/JCO.2001.19.1.164","article-title":"Stereotactic single-dose radiation therapy of liver tumors: results of a phase I\/II trial","volume":"19","author":"Herfarth","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.soc.2020.08.006_bib46","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/02841860600897934","article-title":"Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase i-ii study","volume":"45","author":"M\u00e9ndez Romero","year":"2006","journal-title":"Acta Oncol"},{"issue":"10","key":"10.1016\/j.soc.2020.08.006_bib47","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1200\/JCO.2008.19.6329","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for liver metastases","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.soc.2020.08.006_bib48","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1200\/JCO.2008.20.0600","article-title":"Phase I study of individualized stereotactic body radiotherapy of liver metastases","volume":"27","author":"Lee","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.soc.2020.08.006_bib49","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1245\/s10434-010-1405-5","article-title":"Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases","volume":"18","author":"Rule","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.soc.2020.08.006_bib50","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1186\/1471-2407-14-619","article-title":"Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach","volume":"14","author":"Comito","year":"2014","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.soc.2020.08.006_bib51","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00432-014-1833-x","article-title":"Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer","volume":"141","author":"Scorsetti","year":"2015","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.soc.2020.08.006_bib52","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ijrobp.2009.08.020","article-title":"Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies","volume":"78","author":"Goodman","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.soc.2020.08.006_bib53","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1245\/s10434-015-4579-z","article-title":"A\u00a0phase I dose-escalation trial of single-fraction stereotactic radiation therapy for liver metastases","volume":"23","author":"Meyer","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2020.08.006_bib54","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13014-018-1185-9","article-title":"Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up","volume":"13","author":"Scorsetti","year":"2018","journal-title":"Radiat Oncol"},{"issue":"4","key":"10.1016\/j.soc.2020.08.006_bib55","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1016\/j.prro.2019.02.013","article-title":"NRG oncology\/RTOG 0438: a phase 1 trial of highly conformal radiation therapy for liver metastases","volume":"9","author":"Dawson","year":"2019","journal-title":"Pract Radiat Oncol"},{"issue":"5","key":"10.1016\/j.soc.2020.08.006_bib56","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.ijrobp.2005.01.002","article-title":"A\u00a0phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases","volume":"62","author":"Schefter","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.soc.2020.08.006_bib57","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/j.ijrobp.2018.06.187","article-title":"Phase I trial of Stereotactic Body Radiation Therapy (SBRT) to multiple metastatic sites: a NRG oncology study","volume":"102","author":"Chmura","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.soc.2020.08.006_bib58","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.radonc.2017.03.014","article-title":"Radiobiological parameters of liver and lung metastases derived from tumor control data of 3719 metastases","volume":"123","author":"Klement","year":"2017","journal-title":"Radiother Oncol"},{"issue":"10","key":"10.1016\/j.soc.2020.08.006_bib59","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1200\/JCO.2008.19.6386","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for lung metastases","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.soc.2020.08.006_bib60","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1080\/02841860600919233","article-title":"Image guided respiratory gated hypofractionated Stereotactic Body Radiation Therapy (H-SBRT) for liver and lung tumors: initial experience","volume":"45","author":"Wurm","year":"2006","journal-title":"Acta Oncol"},{"issue":"4","key":"10.1016\/j.soc.2020.08.006_bib61","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.ijrobp.2007.11.026","article-title":"Three-dimensional motion of liver tumors using cine-magnetic resonance imaging","volume":"71","author":"Kirilova","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.soc.2020.08.006_bib62","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijrobp.2012.12.017","article-title":"Three-dimensional, time-resolved, intrafraction motion monitoring throughout stereotactic liver radiation therapy on a conventional linear accelerator","volume":"86","author":"Worm","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.soc.2020.08.006_bib63","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.radonc.2018.07.007","article-title":"Intra-breath-hold residual motion of image-guided DIBH liver-SBRT: an estimation by ultrasound-based monitoring correlated with diaphragm position in CBCT","volume":"129","author":"Vogel","year":"2018","journal-title":"Radiother Oncol"},{"issue":"11","key":"10.1016\/j.soc.2020.08.006_bib64","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1088\/0031-9155\/54\/11\/007","article-title":"Respiratory gating with EPID-based verification: the MDACC experience","volume":"54","author":"Briere","year":"2009","journal-title":"Phys Med Biol"},{"issue":"5","key":"10.1016\/j.soc.2020.08.006_bib65","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.ijrobp.2007.12.023","article-title":"Four-dimensional computed tomography scan analysis of tumor and organ motion at varying levels of abdominal compression during stereotactic treatment of lung and liver","volume":"70","author":"Heinzerling","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.soc.2020.08.006_bib66","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.radonc.2015.08.033","article-title":"Dynamic tumor-tracking radiotherapy with real-time monitoring for liver tumors using a gimbal mounted linac","volume":"117","author":"Iizuka","year":"2015","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.soc.2020.08.006_bib67","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ijrobp.2009.09.008","article-title":"Interfraction and intrafraction changes in amplitude of breathing motion in stereotactic liver radiotherapy","volume":"77","author":"Case","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.soc.2020.08.006_bib68","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ijrobp.2009.03.058","article-title":"Inter- and intrafraction variability in liver position in non-breath-hold stereotactic body radiotherapy","volume":"75","author":"Case","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.soc.2020.08.006_bib69","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.ijrobp.2014.07.028","article-title":"Is diaphragm motion a good surrogate for liver tumor motion?","volume":"90","author":"Yang","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.soc.2020.08.006_bib70","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.ijrobp.2009.10.040","article-title":"Potentials and limitations of guiding liver stereotactic body radiation therapy set-up on liver-implanted fiducial markers","volume":"77","author":"Wunderink","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"17","key":"10.1016\/j.soc.2020.08.006_bib71","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.1088\/0031-9155\/56\/17\/001","article-title":"Treatment precision of image-guided liver SBRT using implanted fiducial markers depends on marker-tumour distance","volume":"56","author":"Seppenwoolde","year":"2011","journal-title":"Phys Med Biol"},{"issue":"13","key":"10.1016\/j.soc.2020.08.006_bib72","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/cncr.29878","article-title":"Solutions that enable ablative radiotherapy for large liver tumors: fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance","volume":"122","author":"Crane","year":"2016","journal-title":"Cancer"},{"issue":"13","key":"10.1016\/j.soc.2020.08.006_bib73","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","article-title":"Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma","volume":"31","author":"Bujold","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.soc.2020.08.006_bib74","doi-asserted-by":"crossref","first-page":"277","DOI":"10.14338\/IJPT-16-00010.1","article-title":"Dosimetric comparison of plans for photon- or proton-beam based radiosurgery of liver metastases","volume":"3","author":"Mondlane","year":"2016","journal-title":"Int J Part Ther"},{"issue":"6","key":"10.1016\/j.soc.2020.08.006_bib75","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.surg.2016.11.034","article-title":"Proton beam radiation as salvage therapy for bilateral colorectal liver metastases not amenable to second-stage hepatectomy","volume":"161","author":"Colbert","year":"2017","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.soc.2020.08.006_bib76","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijrobp.2019.01.076","article-title":"Protons versus photons for unresectable hepatocellular carcinoma: liver decompensation and overall survival","volume":"105","author":"Sanford","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.soc.2020.08.006_bib77","doi-asserted-by":"crossref","first-page":"112","DOI":"10.21037\/jgo.2018.08.17","article-title":"A\u00a0phase I trial of proton stereotactic body radiation therapy for liver metastases","volume":"10","author":"Kang","year":"2019","journal-title":"J\u00a0Gastrointest Oncol"},{"issue":"9","key":"10.1016\/j.soc.2020.08.006_bib78","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx031","article-title":"Phase II study of proton-based stereotactic body radiation therapy for liver metastases: importance of tumor genotype","volume":"109","author":"Hong","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"10185","key":"10.1016\/j.soc.2020.08.006_bib79","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.soc.2020.08.006_bib80","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.soc.2020.08.006_bib81","doi-asserted-by":"crossref","first-page":"e173501","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320720300740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320720300740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:05:35Z","timestamp":1760961935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320720300740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1055320720300740"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2020.08.006","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"External Beam Radiation Therapy for Liver Metastases","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2020.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}